LNA Santé SA (0OR2)
LSE
23.40
+0.30 (+1.30%)
Closed
Oct 8, 2026
Day's Range
22.8023.40
52 wk Range
22.8036.50
Financial Statements - 0OR2 - LNA Santé SA
Revenue
13.85B▲ 31.1%
Net Income
1.09B▲ 511.6%Net Margin 7.9%
EBITDA
2.06B▲ 185.5%
Free Cash Flow
994.00M▼ 33.9%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 13.85B | 10.57B | 20.97B | 20.75B |
| Cost of Goods | 11.05B | 9.11B | 17.75B | 17.08B |
| Gross Profit | 2.80B | 1.45B | 3.21B | 3.67B |
 Operating Expense | - | - | - | - |
| Operating Income | 1.75B | 351M | 1.93B | 2.52B |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -186M | -399M | 29M | 142M |
| Pre Tax Income | 1.18B | -466M | 1.59B | 2.34B |
| Income Tax | 81M | -199M | 326M | 438M |
| Net Income | 1.09B | -267M | 1.27B | 1.90B |
| EPS Basic | 3.36 | -0.82 | 3.83 | - |
| EPS Diluted | 3.34 | -0.82 | 3.8 | - |
| Basic Shares Outstanding | 327.20M | 325.80M | 332.70M | - |
| Diluted Shares Outstanding | 327.20M | 325.80M | 332.70M | - |
| Ebit | - | - | - | - |
| Ebitda | 2.06B | 724M | 2.53B | 3.12B |
| Net Income Continuous Operations | 1.09B | -267M | 1.27B | 1.90B |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
